The Defence Research and Development Organisation (DRDO), which developed 2-Deoxy-D- Glucose (2-DG), a drug used for treatment of Covid-19 patients, has called for Expression of Interest (EoI) to transfer the technology to Indian pharmaceutical industries for production.
from Gadgets Now https://ift.tt/3watoHC
The Defence Research and Development Organisation (DRDO), which developed 2-Deoxy-D- Glucose (2-DG), a drug used for treatment of Covid-19 patients, has called for Expression of Interest (EoI) to transfer the technology to Indian pharmaceutical industries for production.
DRDO invites EoI to transfer technology of '2-DG' Covid treatment drug for bulk production
Related Posts:
Facebook ad boycott organizers see 'no commitment to action' in Mark Zuckerberg meeting- Indian Army has asked soldiers, officers to delete these 89 apps
- Japan Display shares tumble 6% after media report on Apple's full shift to OLED
- Today’s Deals on Amazon: Samsung Galaxy A80 available with 38% off
- Flipkart's 2GUD make foray into social commerce
0 comments:
Post a Comment